Ceftolozane/tazobactam for Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis adult patients: a case series
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10096-021-04218-1.pdf
Reference18 articles.
1. Spoletini G, Kennedy M, Flint L, Graham T, Etherington C, Shaw N et al (2018) Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: real life experience of a large adult CF centre. Pulm Pharmacol Ther 50:82–87. https://doi.org/10.1016/j.pupt.2018.04.007
2. Lambert PA (2002) Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med 95(Suppl 41):22–26
3. Zhanel GG, Chung P, Adam H, Zelenitsky S, Denisuik A, Schweizer F et al (2014) Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli. Drugs 74:31–51. https://doi.org/10.1007/s40265-013-0168-2
4. Sucher AJ, Chahine EB, Cogan P, Fete M (2015) Ceftolozane/tazobactam: a new cephalosporin and β-lactamase inhibitor combination. Ann Pharmacother 49:1046–1056. https://doi.org/10.1177/1060028015593293
5. Bilton D, Canny G, Conway S, Dumcius S, Hjelte L, Proesmans M et al (2011) Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros Off J Eur Cyst Fibros Soc 10(Suppl 2):S79–S81. https://doi.org/10.1016/S1569-1993(11)60012-X
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ceftolozane/Tazobactam for the Treatment of Adults With Cystic Fibrosis: Results From a French Prospective Cohort Study;Open Forum Infectious Diseases;2024-07-30
2. Rational Design and Antimicrobial Potency Assessment of Abaecin Analogues;ACS Biomaterials Science & Engineering;2023-11-21
3. Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance;Antimicrobial Agents and Chemotherapy;2023-08-17
4. The place of new antibiotics for Gram-negative bacterial infections in intensive care: report of a consensus conference;Annals of Intensive Care;2023-07-04
5. New concepts in antimicrobial resistance in cystic fibrosis respiratory infections;Journal of Cystic Fibrosis;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3